The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's 3-Year Dividend Growth Rate or its related term are showing as below:
NSA:GLAXOSMITH'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -33.9 Med: -7.9 Max: 22.4
Current: -3.5
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was 22.40% per year. The lowest was -33.90% per year. And the median was -7.90% per year.
NSA:GLAXOSMITH's 3-Year Dividend Growth Rate is not ranked
in the Drug Manufacturers industry.
Industry Median: 10.2
vs NSA:GLAXOSMITH: -3.50
During the past 12 months, GlaxoSmithKline Consumer Nigeria's average Dividends Per Share Growth Rate was 150.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -3.50% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 6.30% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was -8.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of GlaxoSmithKline Consumer Nigeria PLC is 1.04, which seems too high.
Warning Sign:
GlaxoSmithKline Consumer Nigeria PLC stock dividend yield is close to 5-year low.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of GlaxoSmithKline Consumer Nigeria's 3-Year Dividend Growth Rate
For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GlaxoSmithKline Consumer Nigeria's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of GlaxoSmithKline Consumer Nigeria was 1.04. The lowest was 0.15. And the median was 0.67.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of GlaxoSmithKline Consumer Nigeria PLC is 1.04, which seems too high.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
During the past 13 years, the highest Dividend Yield of GlaxoSmithKline Consumer Nigeria was 14.49%. The lowest was 0.88%. And the median was 4.71%.
Warning Sign:
GlaxoSmithKline Consumer Nigeria PLC stock dividend yield is close to 5-year low.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GlaxoSmithKline Consumer Nigeria 3-Year Dividend Growth Rate Related Terms>
GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSA:GLAXOSMITH has been successfully added to your